Show results for
Refine by
Cancer Disease Equipment & Supplies In Russia
132 equipment items found
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Carubicin hydrochloride also induces apoptosis by a mechanism independent of p53 or hypoxia-inducible factor HIF2. Carubicin hydrochloride has the potential for the research of cancer ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Firmonertinib inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Firmonertinib mesylate inhibits EGFR active mutations as well as the T790M acquired resistant mutation. Firmonertinib mesylate has the potential for the research of cancer diseases, especially advanced non-small cell lung cancer (NSCLC) with EGFR ex20ins ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
NT219 affects IRS1/2 degradation and inhibits STAT3 phosphorylation. NT219 has the potential for the research of cancer ...
Manufactured by:Shine Technologies based inJanesville, WISCONSIN (USA)
SHINE Technologies’ production process results in molybdenum-99 that is of high quality and high purity, resulting in Mo-99 that has high specific activity and is ready for delivery to our medical customers. We believe our production of Mo-99 in the United States will contribute to the reliability of SHINE’s supply in a time of chronic shortages of medical ...
Manufactured by:ProImmune Ltd. based inOxford, UNITED KINGDOM
A clear solution to a long-standing problem. Detecting and targeting specific MHC-peptide complexes is of material interest for understanding many disease conditions better and for developing novel therapeutic interventions. It has been very challenging to develop antibodies that bind selectively to an MHC-peptide combination over a more general MHC ...
Manufactured by:AnaSpec based inFremont, CALIFORNIA (USA)
Matrix metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases capable of digesting extracellular matrix components. MMP-9 (92-kDa gelatinase, collagenase-IV) is involved in a number of diseases such as cancer, angiogenesis, alopecia, and metastasis. MMP-9 is secreted as zymogen with prodomain, gelatin-binding domain ...
Manufactured by:Röchling SE & Co. KG based inMannheim, GERMANY
Care of the patient is shifting towards prevention and early detection of disease. With an increasing presence of cancer, autoimmune and infectious diseases, the need for point-of-care diagnostics is on the rise. Röchling Medical partners with our customers to create medical innovations to help transform how patients are diagnosed and ...
Manufactured by:The Menarini Group based inFlorence, ITALY
Elacestrant is a selective estrogen receptor degrader (SERD) evaluated for potential use as a once daily oral treatment in patients with estrogen receptor positive (ER+)/HER2- advanced or metastatic breast cancer. Studies completed to date, including the positive results from the EMERALD phase 3 trial, indicate that the compound has the potential for use as a single agent or in combination with ...
Manufactured by:Blue Earth Diagnostics based inOxford, UNITED KINGDOM
Diagnostic nuclear medicine is a type of molecular imaging that uses very small amounts of radioisotopes attached to a targeting molecule (radiopharmaceutical1) to diagnose complex diseases such as cancer. Radiopharmaceuticals are able to show the physiological function of the body rather than just the anatomy. Changes in the biochemical activity of cells often ...
by:Pars Isotope Co based inTehran, IRAN
Designed for the extraction of technetium-99m (Tc-99m) in the form of a sodium pertechnetate solution, it serves as an essential tool for labeling SPECT diagnostic radiopharmaceutical kits. It facilitates the diagnosis of various cancers and diseases. Tc-99m is favored in medical diagnostics due to its half-life of 6.01 hours, which limits unnecessary radiation ...
Manufactured by:BioMaxima SA based inLublin, POLAND
BioMaxima was the first in Poland to start production of rapid diagnostic tests. The most popular and flagship product is the fecal occult blood test used for the diagnosis of colorectal cancer. We offer tests for infectious diseases, inflammatory and cancer markers and addictive drugs. Every year, based on the requirements of customers, we are ...
Manufactured by:Everlife CPC Diagnostics Pvt. Ltd. based inChennai, INDIA
ichroma™ II is a compact fully automatic hormone analyzer ,easy-to-use fluorescence-based POCT technology by Boditech POCT. ichroma 2 is used to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases. diseases, autoimmune ...
Manufactured by:AMS Biotechnology (Europe) Ltd. based inAbingdon, UNITED KINGDOM
Breast cancer with adjacent normal breast tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245. Breast carcinoma with adjacent normal breast tissue microarray, containing 10 cases of invasive carcinoma of no special type, 2 adjacent normal breast tissue, duplicate cores per ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
Based on our proven CE-marked MSOT Acuity Echo system further non-CE-certified, customized MSOT Acuity Echo research systems are available upon request to match your clinical research needs in optoacoustic imaging. iThera Medical has been providing optoacoustic systems for clinical research since 2014. Two product lines, the MSOT Acuity Echo and the RSOM Explorer C50 research system, enable ...
Manufactured by:Pepex Biomedical, Inc. based inNorcross, GEORGIA (US) (USA)
3E Catheter Style Sensor Module for In-Hospital Diagnostics for Trend Monitoring for In-Hospital Diagnostics. ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. A broader window of opportunity. Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary cytotoxins (cell-killing compounds), ...
Manufactured by:iThera Medical GmbH based inMunich, GERMANY
The RSOM Explorer C50 features a mobile cart system with a flexible mechanical arm for user-friendly detector positioning on the skin. Laser safety features such as a foot pedal interlock are integrated to fulfill key requirements of the clinical ...
Manufactured by:Virtual Incision based inLincoln, NEVADA (USA)
MIRA’s convenient, capable, compact design empowers surgeons to quickly obtain full multi-quadrant access and work closer to the ...
Manufactured by:Neuros Medical, Inc. based inWilloughby Hills, OHIO (USA)
A growing amputee population: There are over two million people estimated to be living with limb loss in the United States today, and almost 185,000 people have an amputation each year.1 Causes of amputation include peripheral vascular disease, trauma, and cancer.1 Worse yet, the number of amputees is expected to double by ...